Lead Product(s) : Cevimeline Hydrochloride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions
Details : Cevimeline is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Xerostomia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 19, 2013
Lead Product(s) : Cevimeline Hydrochloride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cevimeline Hydrochloride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions
Details : Cevimeline is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Xerostomia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 19, 2013
Lead Product(s) : Cevimeline Hydrochloride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
